Prospective identification of National Institutes of Health category IV prostatitis in men with elevated prostate specific antigen

Journal of Urology

Volumn 164, Issue 5, 2000, Pages 1550-1553

  Potts, Jeannette M ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Biopsy; Prostate; Prostate specific antigen; Prostatitis

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ANTIBIOTIC THERAPY; ANTIGEN DETECTION; ARTICLE; DIAGNOSTIC ACCURACY; HEALTH CARE ORGANIZATION; HUMAN; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATE SECRETION; PROSTATITIS; SCREENING; TRANSRECTAL ULTRASONOGRAPHY; URINALYSIS; URINARY TRACT INFECTION;

EID: 0033786612     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(05)67026-7     Document Type: Article

References (27)

1. Prostate specific antigen and prostatitis. I. Effect of prostatitis on serum PSA in the human and nonhuman primate
2. PSA and prostatitis in men under 50
3. Prostate specific antigen levels in acute and chronic bacterial prostatitis
4. The use of age-specific reference ranges for serum prostate specific antigen in men 60 years old or older
5. The ability of systematic transrectal ultrasound guided biopsy to detect prostate cancer in men with the clinical diagnosis of benign prostatic hyperplasia
6. Patterns of inflammation in prostatic hyperplasia: A histologic and bacteriologic study
7. A review of clinical and pathological prostatitis syndromes
8. Bacteriologic localization patterns in bacterial prostatitis and urethritis
9. The prostate gland: Morphology and pathobiology
10. Elevated serum prostate specific antigen (PSA) related to asymptomatic prostatic inflammation
11. The effect of prostatitis, urinary retention, ejaculation and ambulation on the serum prostate-specific antigen concentration
12. Inflammation in benign prostatic hyperplasia: Correlation with prostate specific antigen value
13. Relationship between serum prostate specific antigen and histological prostatitis in patients with benign prostatic hyperplasia
14. Effect of inflammation and benign prostatic hyperplasia on elevated serum prostate specific antigen levels
15. Inflammatory infiltrate (prostatitis) in whole mounted radical prostatectomy specimens from black and white patients is not an etiology for racial difference in prostate specific antigen
16. Age- and race-specific reference ranges for prostate-specific antigen from a large community-based study
17. Evaluation of percentage of free serum prostate specific antigen to improve specificity of prostate cancer screening
18. The effect of prostate volume, age, total prostate specific antigen level and acute inflammation on the percentage of free serum prostate specific antigen levels in men without clinically detectable prostate cancer
19. Ratio of free-to-total prostate specific antigen in serum cannot distinguish patients with prostate cancer from those with chronic inflammation of the prostate
20. Evaluation of the bacterial flora of the prostate using a 16S rRNA gene based polymerase chain reaction
21. Antibiotic therapy for chronic inflammatory (NIH Category II/IIIa) prostatitis
22. Systematic five region prostate biopsy is superior to sextant method for diagnosing carcinoma of the prostate
23. Risks and complications of transrectal ultrasound guided prostate needle biopsy: A prospective study and review of the literature
24. Repeat screening for prostate cancer after 1-year followup in 984 biopsied men: Clinical and pathological features of detected cancer
25. Clinical and pathologic tumor characteristics of prostate cancer as a function of the number of biopsy cores: A retrospective study
26. Prevalence and predictors of a positive repeat transrectal ultrasound guided biopsy of the prostate
27. Prostatic intraepithelial neoplasia